Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brivaracetam adjunctive therapy for partial-onset seizures
NL-OMON38244Phase 3Active, not recruiting
- Sponsor
- UCB
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of brivaracetam in Focal Onset Epilepsy and focal-onset epileptic seizures (3 arms), sponsored by UCB. Primary endpoints: Primary efficacy variable, Primary efficacy outcome for USA and 1 more. Started Mar 2012; status: active, not recruiting.
02
Drugs
brivaracetam
03
Conditions
Focal Onset Epilepsyfocal-onset epileptic seizures
Beyond the preview
Go deeper on NL-OMON38244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38244.